HH

Ho-Wah Hui

BS Bristol-Myers Squibb: 20 patents #232 of 3,969Top 6%
Abbott: 3 patents #1,951 of 5,431Top 40%
SP Signal Pharmaceuticals: 1 patents #166 of 207Top 85%
📍 Berkeley Heights, NJ: #79 of 1,035 inventorsTop 8%
🗺 New Jersey: #3,122 of 69,400 inventorsTop 5%
Overall (All Time): #169,731 of 4,157,543Top 5%
24
Patents All Time

Issued Patents All Time

Showing 1–24 of 24 patents

Patent #TitleCo-InventorsDate
11883389 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6- dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide Yu Pu 2024-01-30
11406629 Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2022-08-09
11129821 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide Yu Pu 2021-09-28
10835522 Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2020-11-17
10449187 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide Yu Pu 2019-10-22
10376503 Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2019-08-13
10052315 Formulations of 2-(4-chlorophenyl)-N-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide Yu Pu 2018-08-21
9974780 Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2018-05-22
9968627 Solid forms comprising 4-amino-1-β-D-ribofuranosyl-1,3,5-triazin-2(1H)-one and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2018-05-15
9884042 Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide Nathan Boersen, Wai Yip Thomas Lee, Paul Kurtulik 2018-02-06
9808450 Solid forms comprising 3-(4-amino-1-OXO-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2017-11-07
9795650 Romidepsin formulations and uses thereof Lianfeng Huang, Vijay H. Naringrekar, Gang Yang 2017-10-24
9782451 Romidepsin formulations and uses thereof Lianfeng Huang, Vijay H. Naringrekar, Gang Yang 2017-10-10
9757355 Oral dosage forms of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide Ming J. Chen, Thomas Lee, Paul Kurtulik, Sekhar S. Surapaneni 2017-09-12
9695146 Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof G. Patrick Stahly, David Jonaitis, Kevin J. Klopfer 2017-07-04
9616019 Nanosuspension of a poorly soluble drug via microfluidization process Ming J. Chen, Thomas Lee, Paul Kurtulik, Sekhar S. Surapaneni 2017-04-11
9532977 Controlled release oral dosage forms of poorly soluble drugs and uses thereof Ming J. Chen, Xiaole Shen 2017-01-03
9468664 Romidepsin formulations and uses thereof Lianfeng Huang, Vijay H. Naringrekar, Gang Yang 2016-10-18
9463215 Romidepsin formulations and uses thereof Lianfeng Huang, Vijay H. Naringrekar, Gang Yang 2016-10-11
9403829 Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use Terrence Joseph Connolly, Kevin J. Klopfer, William W. Leong, Anil Menon, Amanda Nicole Miklos +7 more 2016-08-02
9023886 Nanosuspension of a poorly soluble drug via microfluidization process Ming J. Chen, Thomas Lee, Paul Kurtulik, Sekhar S. Surapaneni 2015-05-05
8524148 Method of integrating therapeutic agent into a bioerodible medical device Sanjay Shrivastava, John L. Toner, Sandra E. Burke, Keith Cromack, Peter Tarcha +1 more 2013-09-03
6010718 Extended release formulations of erythromycin derivatives Laman A. Al-Razzak, Sheri L. Crampton, Linda E. Gustavson, Nelly Milman, Susan J. Semla 2000-01-04
5082656 Topical antibacterial compositions containing penetration enchancers Chung-Chiang Hsu, Madhu K. Vadnere 1992-01-21